We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Fenner | LSE:FENR | London | Ordinary Share | GB0003345054 | ORD 25P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 609.00 | 609.00 | 609.50 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMFENR
RNS Number : 8162I
Fenner PLC
02 September 2016
2 September 2016
Fenner PLC
("Fenner" or "the Group")
Disposal of Xeridiem Medical Devices, Inc
Fenner PLC announces the disposal yesterday of Xeridiem Medical Devices, Inc ("Xeridiem") to PPC Industries, Inc for a consideration of $10.5 million, payable in cash.
Xeridiem is a manufacturer of minimally-invasive catheters and other single-use medical devices; it is located in Tucson, Arizona, USA.
During the year ended 31 August 2015, Xeridiem achieved an operating profit of $0.2 million before certain non-recurring items and had gross assets of approximately $3.2 million.
The proceeds of the sale will initially be used to reduce Fenner's net indebtedness.
Mark Abrahams, Chief Executive of Fenner PLC, commented as follows:
"Fenner has recently invested significantly in its medical businesses, most particularly through the acquisition of Charter Medical in January 2015 and the construction of state of the art, purpose-built facilities for Secant Medical, which have now entered the testing and certification phases. Together, these businesses provide a platform for exploiting our knowhow in new and growing fields to support our customers' ambitious growth plans.
We believe Xeridiem will bring more synergies to the acquirer whilst the mutually beneficial deal will allow us to focus on the significant growth opportunities in Secant and Charter."
ENDS
For further information please contact:
Fenner PLC Mark Abrahams, Chief Executive 01482 626500 John Pratt, Group Finance Director 01482 626500 Weber Shandwick Financial Nick Oborne / Tom Jenkins 020 7067 0700
Notes:
Fenner PLC is a world leader in reinforced polymer technology, providing local engineered solutions for performance--critical applications.
The information contained within this announcement is deemed by the Company to constitute inside information stipulated under the Market Abuse Regulation (EU) No. 596/2014. Upon the publication of this announcement via the Regulatory Information Service, this inside information is now considered to be in the public domain.
This information is provided by RNS
The company news service from the London Stock Exchange
END
DISUGUUUBUPQURP
(END) Dow Jones Newswires
September 02, 2016 04:01 ET (08:01 GMT)
1 Year Fenner Chart |
1 Month Fenner Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions